Skip to main content
. Author manuscript; available in PMC: 2014 Jul 24.
Published in final edited form as: Biochem Biophys Res Commun. 2006 Aug 28;349(2):533–539. doi: 10.1016/j.bbrc.2006.08.108

Figure 4. Exogenous addition of ADPribosyl cyclase augments, while NADase inhibits osteoclast formation.

Figure 4

Ficol-purified bone marrow cells were plated with either RANK-L and M-CSF alone, or with the addition of 2 to 60 mU Aplaysia ADPribosyl cyclase or 2 to 60 mU of snake venom NADase enzymes. The exogenous addition of ADPribosyl cyclase (Cyclase) augmented osteoclast formation with doses detectable at doses as low as 2 mU. In contrast, the addition of NADase inhibited osteoclast formation, with modest inhibition between 2 to 10 mU, and complete inhibition at 30 mU or greater. The depiction of the differences in enzymatic activity between the Cyclase and NADase is shown in the lower right corner.

HHS Vulnerability Disclosure